CJC-1295 Identified in an Unknown Pharmaceutical Preparation: Forensic Analysis

CJC-1295 (long-acting GHRH analog) was identified in an unknown pharmaceutical preparation through analytical chemistry, highlighting its availability in the unregulated peptide market and anti-doping implications.

Henninge, John et al.·Drug testing and analysis·2010·
RPEP-016262010RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

CJC-1295 (long-acting GHRH analog) was identified in an unknown pharmaceutical preparation through analytical chemistry, highlighting its availability in the unregulated peptide market and anti-doping implications.

Key Numbers

How They Did This

research study.

Why This Research Matters

Relevant for peptide research.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.

Trust & Context

Key Stat:
Key finding CJC-1295 (long-acting GHRH analog) was identified in an unknown pharmaceutical preparation through analytical chemistry, highlighting its availability
Evidence Grade:
emerging evidence.
Study Age:
Published in 2010.
Original Title:
Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.
Published In:
Drug testing and analysis, 2(11-12), 647-50 (2010)
Database ID:
RPEP-01626

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

CJC-1295 Identified in an Unknown Pharmaceutical Preparation: Forensic Analysis

What was found?

CJC-1295 (long-acting GHRH analog) was identified in an unknown pharmaceutical preparation through analytical chemistry, highlighting its availability in the unregulated peptide market and anti-doping implications.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-01626·https://rethinkpeptides.com/research/RPEP-01626

APA

Henninge, John; Pepaj, Milaim; Hullstein, Ingunn; Hemmersbach, Peter. (2010). Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.. Drug testing and analysis, 2(11-12), 647-50. https://doi.org/10.1002/dta.233

MLA

Henninge, John, et al. "Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.." Drug testing and analysis, 2010. https://doi.org/10.1002/dta.233

RethinkPeptides

RethinkPeptides Research Database. "Identification of CJC-1295, a growth-hormone-releasing pepti..." RPEP-01626. Retrieved from https://rethinkpeptides.com/research/henninge-2010-identification-of-cjc1295-a

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.